Virion Therapeutics Presents VRON-0200 Preclinical Data Showing Direct Correlations Between Intrahepatic CD8+ T cells and Hepatitis B Virus Declines (HBV) at EASL 2023

Virion Therapeutics presented preclinical data at the European Association for the Study of Liver Diseases (EASL) annual Congress, showing a direct correlation between vaccine-induced T cells in the liver and hepatitis B virus declines in the blood. The therapeutic vaccine being developed by Virion, VRON-0200, contains key HBV antigens coupled to glycoprotein D (gD), which is a checkpoint modifi..